Mixed Phenotype Acute Leukemia: Clinical Trials

23 trials for Mixed Phenotype Acute Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 recruiting, 4 active not recruiting, 2 completed, 2 terminated. 23 Phase 1, 11 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 123Recruiting 13, Active not recruiting 4, Completed 2, Terminated 2, Unknown 1, Withdrawn 1
Phase 211Recruiting 8, Active not recruiting 1, Completed 1, Unknown 1

Follow Mixed Phenotype Acute Leukemia: new trials by email Literature Review of Mixed Phenotype Acute Leukemia trials Research Report on Mixed Phenotype Acute Leukemia

Trials (filtered) newest first · largest first

All 23 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute Leukemia
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1WithdrawnChildren's Oncology Group2026-09-102026-05-05
A Study of Revumenib and Mezigdomide in People With Leukemia
Revumenib, Mezigdomide - Leukemia, Acute Leukemia
Phase 1 / Phase 2RecruitingMemorial Sloan Kettering Cancer Center522026-01-162026-10-20
Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT
ORCA-T - Acute Myeloid Leukemia, Acute Lymphoid Leukemia
Phase 1RecruitingStanford University242025-12-012026-06-23
Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse
Decitabine, Bone Marrow Aspiration, Bone Marrow Biopsy - Acute Myeloid Leukemia, Acute Undifferentiated Leukemia
Phase 1 / Phase 2RecruitingFred Hutchinson Cancer Center362025-09-232026-05-15
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Dose Level 1, VNX-101, Dose Level 2, VNX-101, Dose Level 3, VNX-101 - B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma
Phase 1 / Phase 2RecruitingVironexis Biotherapeutics Inc.322025-05-302026-10-26
Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK) for the Treatment of Newly Diagnosed Adverse Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia
Phase 1Active not recruitingFred Hutchinson Cancer Center302023-12-182026-07-29
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Tagraxofusp, Fludarabine, Cytarabine - Hematologic Malignancy, AML
Phase 1RecruitingTherapeutic Advances in Childhood Leukemia Consortium542022-11-112024-12-06
Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute Leukemia
Dasatinib, Methotrexate, Prednisone - B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
Phase 1Active not recruitingOHSU Knight Cancer Institute202022-09-022026-05-06
Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
Orca-Q - Acute Myeloid Leukemia, Acute Lymphoid Leukemia
Phase 1 / Phase 2RecruitingUniversity of Florida402022-08-162026-10-30
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Biospecimen Collection - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1 / Phase 2RecruitingPedAL BCU, LLC9602022-04-182026-08-25
Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
MRX-2843 - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia
Phase 1RecruitingMeryx, Inc.502022-04-012026-01-08
A Study of Revumenib in Combination With Chemotherapy in Participants With R/R Acute Leukemia
Revumenib, Chemotherapy Regimen 1, Chemotherapy Regimen 2 - Relapsed/Refractory Leukemias, Acute Lymphoblastic Leukemia
Phase 1CompletedSyndax Pharmaceuticals302022-03-092024-08-13
Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms
Cladribine, Cytarabine, Mitoxantrone - Acute Biphenotypic Leukemia, Acute Myeloid Leukemia
Phase 1 / Phase 2RecruitingUniversity of Washington622022-02-042026-11-06
Humanized CD7 CAR T-cell Therapy for r/r CD7+ Acute Leukemia
Humanized CD7 CAR-T cells - T Lymphoblastic Leukemia/Lymphoma, Mixed Phenotype Acute Leukemia
Phase 1 / Phase 2UnknownThe First Affiliated Hospital of Soochow University202021-06-012021-06-02
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
revumenib, cobicistat - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia
Phase 1 / Phase 2RecruitingSyndax Pharmaceuticals4472019-11-052026-10-09
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
Ziftomenib, Midazolam, Itraconazole - Advanced Malignant Neoplasm, Acute Myeloid Leukemia
Phase 1 / Phase 2Active not recruitingKura Oncology, Inc.2632019-09-122026-05-13
Vorinostat Dose-escalation After Allogeneic Hematopoietic Cell Transplantation
Vorinostat, Azacitidine Injection - Acute Myeloid Leukemia, Myelodysplastic Syndromes
Phase 1Active not recruitingJohns Hopkins All Children's Hospital152019-05-012026-07-15
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
OrcaGraft (Orca-Q) - Acute Myeloid Leukemia, Myelodysplastic Syndromes
Phase 1RecruitingOrca Biosystems, Inc.3002019-04-082026-09-29
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR, Bone Marrow Aspiration, Biospecimen Collection - Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia
Phase 1RecruitingFred Hutchinson Cancer Center242018-02-232026-05-18
211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
Cyclosporine, Fludarabine Phosphate, Mycophenolate Mofetil - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Phase 1 / Phase 2RecruitingFred Hutchinson Cancer Center752017-10-242026-06-22

Showing 20 of 23. Sign in to see all of them.

Narrower conditions

Leukemia, Biphenotypic, Acute (23)  ·  Leukemia, Myeloid, Acute (19)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (14)  ·  Myelodysplastic Syndromes (7)  ·  Leukemia (6)  ·  Hematologic Neoplasms (3)  ·  Leukemia, Myelomonocytic, Chronic (3)  ·  Leukemia, Myelomonocytic, Juvenile (3)  ·  Anemia, Refractory, with Excess of Blasts (2)  ·  Blastic Plasmacytoid Dendritic Cell Neoplasm (2)  ·  Burkitt Lymphoma (2)  ·  Hodgkin Disease (2)  ·  Lymphoma (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Blast Crisis (1)

Broader conditions

Hematologic Diseases (23)  ·  Hemic and Lymphatic Diseases (23)  ·  Immune System Diseases (23)  ·  Immunoproliferative Disorders (23)  ·  Leukemia, Lymphoid (23)  ·  Lymphatic Diseases (23)  ·  Lymphoproliferative Disorders (23)  ·  Neoplasms (23)  ·  Neoplasms by Histologic Type (23)  ·  Leukemia, Myeloid (19)  ·  Leukemia (17)  ·  Bone Marrow Diseases (10)  ·  Disease Attributes (6)  ·  Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)

Interventions

Cytarabine (6)  ·  Specimen Handling (5)  ·  Biopsy (4)  ·  revumenib (4)  ·  Granulocyte Colony-Stimulating Factor (3)  ·  Methotrexate (3)  ·  X-Rays (3)  ·  fludarabine (3)  ·  Azacitidine (2)  ·  Calcium Dobesilate (2)  ·  Cladribine (2)  ·  Decitabine (2)  ·  Dexamethasone (2)  ·  Filgrastim (2)  ·  Hydrocortisone (2)

Sponsors

Fred Hutchinson Cancer Center (5)  ·  Syndax Pharmaceuticals (2)  ·  Children's Oncology Group (1)  ·  Ehab L Atallah (1)  ·  Johns Hopkins All Children's Hospital (1)  ·  Kura Oncology, Inc. (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  Meryx, Inc. (1)  ·  OHSU Knight Cancer Institute (1)  ·  Orca Biosystems, Inc. (1)  ·  PedAL BCU, LLC (1)  ·  Roncarolo, Maria Grazia, MD (1)  ·  Stanford University (1)  ·  The First Affiliated Hospital of Soochow University (1)  ·  Therapeutic Advances in Childhood Leukemia Consortium (1)

Countries

United States (21)  ·  Canada (4)  ·  Australia (3)  ·  France (2)  ·  Germany (2)  ·  Italy (2)  ·  Puerto Rico (2)  ·  Spain (2)  ·  Belgium (1)  ·  China (1)  ·  Israel (1)  ·  Lithuania (1)  ·  Netherlands (1)  ·  New Zealand (1)

Top investigators

Adam Lamble, MD (1)  ·  Angela R Smith, M.D. (1)  ·  Ben K Watkins (1)  ·  Brenda M. Sandmaier (1)  ·  Cassandra Josephson, MD (1)  ·  Ehab L Atallah, MD (1)  ·  Elizabeth Krakow (1)  ·  Jacob Appelbaum, MD, PhD (1)  ·  James S McClellan, MD, PhD (1)  ·  Jessica T Leonard (1)  ·  Jordan Milner, MD (1)  ·  Joshua Zeidner, MD (1)  ·  Kuo-Kai Chin, MD (1)  ·  Lori Muffly (1)  ·  Mary-Beth M. Percival (1)

Results publications

PMID 33741715, PMID 34267079, PMID 30335787, PMID 32077361, PMID 36175988, PMID 36922593, PMID 38683966, PMID 39121437, PMID 39170618, PMID 39362248, PMID 40332046, PMID 40535475, PMID 40997296, PMID 41621809

NIH funding

P01CA049605 (1), P01CA078902 (1), P30CA015704 (1), U10CA180886 (1), UM1CA228823 (1)